Related Experiment Video
Updated: Feb 1, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
3D echo derived right ventricular principal surface strain in pulmonary arterial hypertension
Hannah Takahashi Oakland1, Lavanya Bellumkonda2, Lissa Sugeng2
1Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University, Atlanta, Georgia, United States.
None:
Traditional echocardiographic metrics of right ventricular (RV) function, including tricuspid annular plane systolic excursion and two-dimensional (2-D) strain, are limited to the description of longitudinal systolic function. These metrics, however, fail to account for the complex, three-dimensional (3-D) deformation of the RV. 3-D echocardiograms (3DE) were obtained simultaneously during clinically indicated right heart catheterization (RHC). We determined the maximum principal surface strain (PSMax) and angle (ϴMax) of RV surface deformation in pulmonary arterial hypertension (PAH) and control patients. We compared 22 control patients to 37 patients with PAH, of whom 11 met hemodynamic criteria for right heart (RH) failure. Compared with 2-D descriptors of RV function, PSMax was significantly different between controls and patients with PAH and between PAH patients with and without RH failure. ϴMax was progressively oriented longitudinally in PAH patients without RH failure compared to PAH patients with RH failure [37.5° (34.3° to 40.8°) vs. 34.3° (32.1° to 36.2°), P = 0.042] and in PAH patients with worse New York Heart Association functional class. Thirty-day outcomes were significantly different with an optimal cutoff of PSMax of -21.4%, with a hazard ratio of 6.8 (95% CI 1.3 to 35.2, P = 0.022). PSMax is a robust marker of RH failure and provides prognostic value in PAH beyond conventional 2-D descriptors of RH function. Progressive longitudinal deformation of ϴMax is associated with worse RH function and functional class.NEW & NOTEWORTHY Impaired PSMax is associated with worse RV systolic function and outcomes in PAH when compared with conventional 2-D metrics of RV systolic function, while ϴMax is progressively oriented longitudinally in PAH patients with RH failure compared to those without RH failure, potentially reflecting an echocardiographic representation of maladaptive RV myofiber reorientation. PSMax and ϴMax represent a powerful and concise way to describe RV systolic function that may prove useful in the care of PAH patients.
More Related Videos
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
09:22Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...